Avitar Inc. (OTCMKTS:AVTI – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Avitar shares last traded at $0.00, with a volume of 0 shares changing hands.
Avitar Trading Down 100.0%
Avitar Company Profile
Avitar, Inc is a holding company which through its subsidiaries designs, develops, manufactures, and markets diagnostic test products and proprietary hydrophilic polyurethane foam disposables for medical, diagnostics, dental, and consumer applications in the United States. It offers ORALscreen 4 and ORALscreen DRUGOMETER, the oral fluid-based onsite assay systems, for detecting drugs of abuse, such as opiates, including heroin, morphine, codeine, and synthetic opiates comprising oxycocone-oxycontin, percoset, and hydrocodone-vicodin; cocaine such as crack; marijuana; and methamphetamines, including meth and ecstasy.
Read More
- Five stocks we like better than Avitar
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Avitar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avitar and related companies with MarketBeat.com's FREE daily email newsletter.
